Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Sales (2016 - 2025)

Historic Return on Sales for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q1 2025 value amounting to 0.0%.

  • Lifecore Biomedical, Inc. \De\'s Return on Sales fell 200.0% to 0.0% in Q1 2025 from the same period last year, while for Feb 2025 it was 0.0%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.02% for FY2024, which is 3600.0% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Return on Sales of 0.0% as of Q1 2025, which was down 200.0% from 0.01% recorded in Q4 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Return on Sales registered a high of 0.08% during Q3 2023, and its lowest value of 1.84% during Q2 2022.
  • Moreover, its 5-year median value for Return on Sales was 0.05% (2021), whereas its average is 0.32%.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Return on Sales plummeted by -17900bps in 2022, and later soared by 17600bps in 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Return on Sales (Quarter) stood at 1.8% in 2021, then surged by 91bps to 0.16% in 2022, then soared by 100bps to 0.0% in 2023, then surged by 916bps to 0.01% in 2024, then crashed by -100bps to 0.0% in 2025.
  • Its last three reported values are 0.0% in Q1 2025, 0.01% for Q4 2024, and 0.01% during Q3 2024.